Grosu, Anca-Ligia.
Grosu, A.-L. (Anca-Ligia)
Anca Grosu deutsche Radiologin und Onkologin sowie Hochschullehrerin
VIAF ID: 612147665803360670009 ( Personal )
Permalink: http://viaf.org/viaf/612147665803360670009
Preferred Forms
- 100 0 _ ‡a Anca Grosu ‡c deutsche Radiologin und Onkologin sowie Hochschullehrerin
-
- 100 1 _ ‡a Grosu, A.-L. ‡q (Anca-Ligia)
- 100 1 _ ‡a Grosu, Anca-Ligia
-
- 100 1 _ ‡a Grosu, Anca-Ligia
- 100 1 _ ‡a Grosu, Anca-Ligia
- 100 1 _ ‡a Grosu, Anca-Ligia
-
-
4xx's: Alternate Name Forms (8)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models | |
Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer : a prospective pilot study | |
impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer | |
Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990 | |
Influence of adjuvant vs early salvage radiotherapy on lethality in men with high risk for recurrence following radical prostatectomy for prostate cancer | |
influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation | |
Influence of urethra sparing on tumor control probability and normal tissue complication probability in focal dose escalated hypofractionated radiotherapy: A planning study based on histopathology reference | |
Interdisziplinärer Expertenkonsensus zu Innovationen der bildgebenden Diagnostik und radionuklidbasierten Therapien des fortgeschrittenen Prostatakarzinoms = Interdisciplinary expert consensus on innovations in imaging diagnostics and radionuclide-based therapies for advanced prostate cancer | |
Intraindividual comparison between [18F] PSMA-1007 PET/CT and multiparametric MRI for radiotherapy planning in primary prostate cancer patients | |
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis | |
Intraoperative radiotherapy in abdominal surgery - own experiences | |
Investigation and benchmarking of U-Nets on prostate segmentation tasks | |
Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? | |
Isotropic expansion of the intraprostatic gross tumor volume of primary prostate cancer patients defined in MRI - a correlation study with whole mount histopathological information as reference | |
judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma | |
Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection | |
Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites | |
Management of medial sphenoid wing meningioma involving the cavernous sinus: a single-center series of 105 cases | |
Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous | |
Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy | |
MRT- und Cholin-PET/CT-gesteuerte Salvage Präzisionsstrahlentherapie nach radikaler Prostatektomie: Klinische Ergebnisse bei Patienten mit Prostatakarzinom | |
A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa | |
Multipotent mesenchymal stromal cells are sensitive to thermic stress - potential implications for therapeutic hyperthermia | |
Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA — a study protocol | |
A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT | |
Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas | |
Opportunities and alternatives of modern radiation oncology and surgery for the management of resectable brain metastases | |
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost - tutorial and efficacy of complete directional hippocampal blocking | |
Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients | |
Paravertebral muscle training in patients with unstable spinal metastases receiving palliative radiotherapy : an exploratory randomized feasibility trial | |
particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond? | |
Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study | |
Patterns-of-Care analysis for radiotherapy of elderly head-and-neck cancer patients: a trinational survey in Germany, Austria and Switzerland | |
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results? | |
Personalized treatment of brain metastases: evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review) | |
Positron emission tomography (PET) imaging of prostate Cancer with a gastrin releasing peptide receptor antagonist - from mice to men | |
Preserving the legacy of reirradiation: a narrative review of historical publications | |
Professor Dr. Peter Vaupel zum 80. Geburtstag | |
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas | |
Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition | |
Proteome profiling of primary pancreatic ductal adenocarcinomas undergoing additive chemoradiation link ALDH1A1 to early local recurrence and chemoradiation resistance | |
PSMA-PET/MRI-based focal dose escalation in patients with primary prostate cancer treated with stereotactic body radiation therapy (HypoFocal-SBRT): study protocol of a randomized, multicentric phase III trial | |
Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease | |
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference | |
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies | |
Radiotherapeutic management of cervical lymph node metastases from an unknown primary site : experiences from a large cohort treated with modern radiation techniques | |
Radiotherapy for nonagenarians: the value of biological versus chronological age | |
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) | |
Recent advances of PET imaging in clinical radiation oncology | |
Recommendation of regional hyperthermia in the treatment of breast cancer | |
Retrospektive Evaluation der Tumorkontrolle und der MR-morphologischen Veränderungen nach Ganzhirnbestrahlung mit Hippocampusschonung und Dosiseskalation bei multiplen Hirnmetastasen | |
Rezidivmuster nach perkutaner Strahlentherapie mit und ohne zusätzliche fokale Dosiseskalation innerhalb der randomisierten FLAME-Studie für das lokale Prostatakarzinom | |
Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer | |
role of palliative radiotherapy in the treatment of spinal bone metastases from head and neck tumors - a multicenter analysis of a rare event | |
Short survival time after palliative whole brain radiotherapy: can we predict potential overtreatment by use of a nomogram? | |
Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer | |
Stereotactic body radiotherapy for renal cell carcinoma in patients with von Hippel–Lindau disease - results of a prospective trial | |
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen | |
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer | |
Target Volume Definition in Radiation Oncology | |
Towards improving the efficacy of PSMA-targeting radionuclide therapy for late-stage prostate cancer - combination strategies | |
Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy | |
Tumor-treating fields concomitant with sorafenib in advanced hepatocellular cancer: results of the HEPANOVA Phase II Study | |
Überlebensdaten, Progressionsmuster und Toxizität nach Strahlentherapie von niedrig gradigen Gliomen | |
Uncovering the invisible - prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer | |
Validation of the graded prognostic assessment for Melanoma using molecular markers (Melanoma-molGPA) | |
value of laboratory parameters for anemia, renal function, systemic inflammation and nutritional status as predictors for outcome in elderly patients with head-and-neck cancers | |
value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer | |
value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation | |
value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly | |
value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts | |
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer | |
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG) |